Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin

International Journal of Oncology

Volumn 35, Issue 4, 2009, Pages 921-939

  Sanovic, Renata ^a   Krammer, Barbara ^b   Grumboeck, Sandra ^b   Verwanger, Thomas ^b  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Apoptosis; cDNA array; Gene expression; Hypericin; Photodynamic; Real time PCR

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE DOMAIN 10 PROTEIN; ADAM PROTEIN; ALPHA3 INTEGRIN; CALNEXIN; CELL NUCLEUS RECEPTOR; CYTOCHROME P450 1B1; DEOXYCYTIDINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; HISTONE H3; HYPERICIN; LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NUCLEAR RECEPTOR 4A2; PHOSPHORUS 33; PROTEIN C JUN; RAS AND RAB INTERACTOR 2 PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SEPARATION; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; CYTOSKELETON; ENDOCYTOSIS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; NUCLEOTIDE SEQUENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERYLENE; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TIME FACTORS;

EID: 70449413101     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000407     Document Type: Article

References (111)

1. Agostinis P, Vantieghem A, Merlevede W and de Witte PA: Hypericin in cancer treatment: more light on the way. Int J Biochem Cell Biol 34: 221-241, 2002. (Pubitemid 34159138)
2. D'Hallewin MA, De Witte PA, Waelkens E, Merlevede W and Baert L: Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J Urol 164: 349-351, 2000.
3. Boiy A, Roelandts R and de Witte PA: Influence of application and formulation factors on the penetration of hypericin in normal mouse skin and UV induced skin tumors. J Photochem Photobiol B 89: 156-162, 2007. (Pubitemid 350154475)
4. Boiy A, Roelandts R, van den Oord J and de Witte PA: Photo-sensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin. Br J Dermatol 158: 360-369, 2008.
5. Kamuhabwa AR, Roelandts R and de Witte PA: Skin photo-sensitization with topical hypericin in hairless mice. J Photochem Photobiol B 53: 110-114, 1999. (Pubitemid 30047593)
6. Alecu M, Ursaciuc C, Halalau F, Coman G, Merlevede W, Waelkens E and de Witte P: Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res 18: 4651-4654, 1998. (Pubitemid 29042039)
7. Olivo M, Du HY and Bay BH: Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. Curr Clin Pharmacol 1: 217-222, 2006.
8. Kacerovska D, Pizinger K, Majer F and Smid F: Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract - a pilot study. Photochem Photobiol 84: 779-785, 2008. (Pubitemid 351589362)
9. Saw CL, Olivo M, Soo KC and Heng PW: Delivery of hypericin for photodynamic applications. Cancer Lett 241: 23-30, 2006.
10. Buytaert E, Matroule JY, Durinck S, Close P, Kocanova S, Vandenheede JR, de Witte PA, Piette J and Agostinis P: Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 27: 1916-1929, 2008.
11. Berlanda J, Kiesslich T, Oberdanner CB, Obermair FJ, Krammer B and Plaetzer K: Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells. J Environ Pathol Toxicol Oncol 25: 173-188, 2006. (Pubitemid 43341239)
12. Aberger F, Costa-Pereira AP, Schlaak JF, Williams TM, O'Shaughnessy RF, Hollaus G, Kerr IM and Frischauf AM: Analysis of gene expression using high-density and IFN-gamma- specific low-density cDNA arrays. Genomics 77: 50-57, 2001. (Pubitemid 32826485)
13. Vandesompele J, De Preter K, Pattyn F, Poppe B, van Roy N, De Paepe A and Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: Research0034, 2002.
14. Calzada MJ, Annis DS, Zeng B, Marcinkiewicz C, Banas B, Lawler J, Mosher DF and Roberts DD: Identification of novel beta1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J Biol Chem 279: 41734-41743, 2004. (Pubitemid 39313619)
15. Kazerounian S, Yee KO and Lawler J: Thrombospondins in cancer. Cell Mol Life Sci 65: 700-712, 2008.
16. Lawler J: Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6: 1-12, 2002. (Pubitemid 44133979)
17. Bruno RD and Njar VC: Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem 15: 5047-5060, 2007. (Pubitemid 46880385)
18. McFadyen MC, McLeod HL, Jackson FC, Melvin WT, Doehmer J and Murray GI: Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. Biochem Pharmacol 62: 207-212, 2001. (Pubitemid 32522940)
19. McFadyen MC, Melvin WT and Murray GI: Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol Cancer Ther 3: 363-371, 2004.
20. Saito K, Murai J, Kajiho H, Kontani K, Kurosu H and Katada T: A novel binding protein composed of homophilic tetramer exhibits unique properties for the small GTPase Rab5. J Biol Chem 277: 3412-3418, 2002. (Pubitemid 34953210)
21. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D and Saftig P: ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 102: 9182-9187, 2005. (Pubitemid 40923538)
22. Delom F, Emadali A, Cocolakis E, Lebrun JJ, Nantel A and Chevet E: Calnexin-dependent regulation of tunicamycin-induced apoptosis in breast carcinoma MCF-7 cells. Cell Death Differ 14: 586-596, 2007. (Pubitemid 46259966)
23. Fontanini A, Chies R, Snapp EL, Ferrarini M, Fabrizi GM and Brancolini C: Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants. J Biol Chem 280: 2378-2387, 2005.
24. Brakebusch C and Fassler R: Beta 1 integrin function in vivo: adhesion, migration and more. Cancer Metastasis Rev 24: 403-411, 2005.
25. Staniszewska I, Zaveri S, Del Valle L, Oliva I, Rothman VL, Croul SE, Roberts DD, Mosher DF, Tuszynski GP and Marcinkiewicz C: Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res 100: 1308-1316, 2007. (Pubitemid 46742921)
26. Shakibaei M, Csaki C and Mobasheri A: Diverse roles of integrin receptors in articular cartilage. Adv Anat Embryol Cell Biol 197: 1-60, 2008.
27. Kim GS, Choi YK, Song SS, Kim WK and Han BH: MKP-1 contributes to oxidative stress-induced apoptosis via inactivation of ERK1/2 in SH-SY5Y cells. Biochem Biophys Res Commun 338: 1732-1738, 2005.
28. Li J, Gorospe M, Hutter D, Barnes J, Keyse SM and Liu Y: Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol 21: 8213-8224, 2001. (Pubitemid 33051810)
29. Owens DM and Keyse SM: Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203-3213, 2007. (Pubitemid 46763015)
30. Serini S, Trombino S, Oliva F, Piccioni E, Monego G, Resci F, Boninsegna A, Picci N, Ranelletti FO and Calviello G: Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Apoptosis 13: 1172-1183, 2008.
31. Karin M, Liu Z and Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246, 1997.
32. Liebermann DA, Gregory B and Hoffman B: AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int J Oncol 12: 685-700, 1998. (Pubitemid 28097302)
33. Smith AG, Luk N, Newton RA, Roberts DW, Sturm RA and Muscat GE: Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor sub-group in melanocytic cells. J Biol Chem 283: 12564-12570, 2008.
34. Yokota H, Goldring MB and Sun HB: CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J Biol Chem 278: 47275-47280, 2003. (Pubitemid 37452316)
35. Oh-Hashi K, Maruyama W and Isobe K: Peroxynitrite induces GADD34, 45, and 153 VIA p38 MAPK in human neuro-blastoma SH-SY5Y cells. Free Radic Biol Med 30: 213-221, 2001. (Pubitemid 32121799)
36. Yagi A, Hasegawa Y, Xiao H, Haneda M, Kojima E, Nishikimi A, Hasegawa T, Shimokata K and Isobe K: GADD34 induces p53 phosphorylation and p21/WAF1 transcription. J Cell Biochem 90: 1242-1249, 2003. (Pubitemid 37485058)
37. Law SF, O'Neill GM, Fashena SJ, Einarson MB and Golemis EA: The docking protein HEF1 is an apoptotic mediator at focal adhesion sites. Mol Cell Biol 20: 5184-5195, 2000.
38. Seo S, Ichikawa M and Kurokawa M: Structure and function of cas-L and integrin-mediated signaling. Crit Rev Immunol 26: 391-406, 2006. (Pubitemid 44785488)
39. Singh M, Cowell L, Seo S, O'Neill G and Golemis E: Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional coordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys 48: 54-72, 2007. (Pubitemid 47345633)
40. Hultquist A, Cetinkaya C, Wu S, Castell A, Erlandsson A and Larsson LG: Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts. Mol Cancer Res 2: 464-476, 2004. (Pubitemid 39121509)
41. Roussel MF, Ashmun RA, Sherr CJ, Eisenman RN and Ayer DE: Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 16: 2796-2801, 1996. (Pubitemid 26161283)
42. Choi HS, Kang BS, Shim JH, Cho YY, Choi BY, Bode AM and Dong Z: Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity. FASEB J 22: 113-126, 2008.
43. Chung MJ, Hogstrand C and Lee SJ: Cytotoxicity of nitric oxide is alleviated by zinc-mediated expression of antioxidant genes. Exp Biol Med 231: 1555-1563, 2006. (Pubitemid 44547850)
44. Sciavolino PJ and Vilcek J: Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. Cytokine 7: 242-250, 1995.
45. Hao Q and Maret W: Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J Alzheimers Dis 8: 161-170, 2005. (Pubitemid 43230133)
46. Lu H, Hunt DM, Ganti R, Davis A, Dutt K, Alam J and Hunt RC: Metallothionein protects retinal pigment epithelial cells against apoptosis and oxidative stress. Exp Eye Res 74: 83-92, 2002. (Pubitemid 34948268)
47. Grotewold L and Ruther U: The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. EMBO J 21: 966-975, 2002. (Pubitemid 34206169)
48. Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ and Shaughnessy JD Jr: The role of Dickkopf-1 in bone development, homeostasis and disease. Blood (In press).
49. Han C, Chen T, Li N, Yang M, Wan T and Cao X: HDJC9, a novel human type C DnaJ/HSP40 member interacts with and cochaperones HSP70 through the J domain. Biochem Biophys Res Commun 353: 280-285, 2007.
50. Kim SA, Chang S, Yoon JH and Ahn SG: TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination. FEBS Lett 582: 734-740, 2008.
51. Badock V, Steinhusen U, Bommert K, Wittmann-Liebold B and Otto A: Apoptosis-induced cleavage of keratin 15 and keratin 17 in a human breast epithelial cell line. Cell Death Differ 8: 308-315, 2001. (Pubitemid 32288177)
52. Kirfel J, Magin TM and Reichelt J: Keratins: a structural scaffold with emerging functions. Cell Mol Life Sci 60: 56-71, 2003. (Pubitemid 36223117)
53. Cohen-Kerem R, Madah W, Sabo E, Rahat MA, Greenberg E and Elmalah I: Cytokeratin-17 as a potential marker for squamous cell carcinoma of the larynx. Ann Otol Rhinol Laryngol 113: 821-827, 2004. (Pubitemid 39362228)
54. Nilsson JA and Cleveland JL: Myc pathways provoking cell suicide and cancer. Oncogene 22: 9007-9021, 2003.
55. Zhang W and Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18, 2002.
56. Benaud CM and Dickson RB: Regulation of the expression of c-Myc by beta1 integrins in epithelial cells. Oncogene 20: 759-768, 2001. (Pubitemid 32179344)
57. Austin RC, Lentz SR and Werstuck GH: Role of hyperhomo-cysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 (Suppl. 1): S56-S64, 2004. (Pubitemid 39136799)
58. Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ and Austin RC: TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J Biol Chem 278: 30317-30327, 2003. (Pubitemid 36962426)
59. Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y and Kelly K: TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. BMC Cancer 8: 189, 2008.
60. Nagai MA, Fregnani JH, Netto MM, Brentani MM and Soares FA: Down-regulation of PHLDA1 gene expression is associated with breast cancer progression. Breast Cancer Res Treat 106: 49-56, 2007. (Pubitemid 47498092)
61. Vassen L, Wegrzyn W and Klein-Hitpass L: Human insulin receptor substrate-2 (IRS-2) is a primary progesterone response gene. Mol Endocrinol 13: 485-494, 1999. (Pubitemid 29113880)
62. Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, Mineyama T, Ogata H, Tokuyama K, Ohsugi M, Sasako T, Moroi M, Sugi K, Kakuta S, Iwakura Y, Noda T, Ohnishi S, Nagai R, Tobe K, Terauchi Y, Ueki K and Kadowaki T: Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab 8: 49-64, 2008. (Pubitemid 351859226)
63. Sadagurski M, Weingarten G, Rhodes CJ, White MF and Wertheimer E: Insulin receptor substrate 2 plays diverse cell-specific roles in the regulation of glucose transport. J Biol Chem 280: 14536-14544, 2005. (Pubitemid 40562796)
64. Wang H, Kouri G and Wollheim CB: ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci 118: 3905-3915, 2005. (Pubitemid 41410274)
65. Nobes CD, Lauritzen I, Mattei MG, Paris S, Hall A and Chardin P: A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J Cell Biol 141: 187-197, 1998. (Pubitemid 28182651)
66. Boswell SA, Ongusaha PP, Nghiem P and Lee SW: The protective role of a small GTPase RhoE against UVB-induced DNA damage in keratinocytes. J Biol Chem 282: 4850-4858, 2007. (Pubitemid 47100923)
67. Kinsey GR, Blum JL, Covington MD, Cummings BS, McHowat J and Schnellmann RG: Decreased iPLA2gamma expression induces lipid peroxidation and cell death and sensitizes cells to oxidant-induced apoptosis. J Lipid Res 49: 1477-1487, 2008.
68. Blanc L, Barres C, Bette-Bobillo P and Vidal M: Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2. Blood 110: 3407-3416, 2007. (Pubitemid 350110308)
69. Gadd ME, Broekemeier KM, Crouser ED, Kumar J, Graff G and Pfeiffer DR: Mitochondrial iPLA2 activity modulates the release of cytochrome c from mitochondria and influences the permeability transition. J Biol Chem 281: 6931-6939, 2006. (Pubitemid 43847455)
70. 2+- independent phospholipase A2 augments spontaneous fatty acid release. J Biol Chem 275: 18248-18258, 2000.
71. Lupo G, Nicotra A, Giurdanella G, Anfuso CD, Romeo L, Biondi G, Tirolo C, Marchetti B, Ragusa N and Alberghina M: Activation of phospholipase A(2) and MAP kinases by oxidized low-density lipoproteins in immortalized GP8.39 endothelial cells. Biochim Biophys Acta 1735: 135-150, 2005. (Pubitemid 40961969)
72. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G and Wesselborg S: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730, 2003. (Pubitemid 36724936)
73. Kong WJ, Liu J and Jiang JD: Human low-density lipoprotein receptor gene and its regulation. J Mol Med 84: 29-36, 2006. (Pubitemid 43099521)
74. Li C, Kraemer FB, Ahlborn TE and Liu J: Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter. J Biol Chem 274: 6747-6753, 1999. (Pubitemid 29111097)
75. Heald R, McLoughlin M and McKeon F: Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74: 463-474, 1993. (Pubitemid 23244612)
76. Yuan H, Xie YM and Chen IS: Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis. J Virol 77: 2063-2070, 2003. (Pubitemid 36110019)
77. Walter SA, Guadagno SN and Ferrell JE Jr: Activation of Wee1 by p42 MAPK in vitro and in cycling xenopus egg extracts. Mol Biol Cell 11: 887-896, 2000.
78. Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL and Liang G: Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest 113: 1168-1175, 2004. (Pubitemid 38544102)
79. Qin X, Xie X, Fan Y, Tian J, Guan Y, Wang X, Zhu Y and Wang N: Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipo-genesis in obese diabetic mice. Hepatology 48: 432-441, 2008.
80. Ozawa N, Shichiri M, Fukai N, Yoshimoto T and Hirata Y: Regulation of adrenomedullin gene transcription and degradation by the c-myc gene. Endocrinology 145: 4244-4250, 2004. (Pubitemid 39120573)
81. Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K and Fujita T: Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 41: 1080-1085, 2003. (Pubitemid 36548606)
82. Ma Y and Hendershot LM: Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress. J Biol Chem 278: 34864-34873, 2003. (Pubitemid 37102245)
83. Lange PS, Chavez JC, Pinto JT, Coppola G, Sun CW, Townes TM, Geschwind DH and Ratan RR: ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med 205: 1227-1242, 2008. (Pubitemid 351679695)
84. Hung WJ, Roberson RS, Taft J and Wu DY: Human BAG-1 proteins bind to the cellular stress response protein GADD34 and interfere with GADD34 functions. Mol Cell Biol 23: 3477-3486, 2003. (Pubitemid 36539180)
85. Townsend PA, Stephanou A, Packham G and Latchman DS: BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol 37: 251-259, 2005.
86. Foos G, Garcia-Ramirez JJ, Galang CK and Hauser CA: Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J Biol Chem 273: 18871-18880, 1998. (Pubitemid 28366274)
87. Sanij E, Hatzistavrou T, Hertzog P, Kola I and Wolvetang EJ: Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome. Biochem Biophys Res Commun 287: 1003-1008, 2001.
88. Foulds CE, Nelson ML, Blaszczak AG and Graves BJ: Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol 24: 10954-10964, 2004.
89. Wolvetang EJ, Wilson TJ, Sanij E, Busciglio J, Hatzistavrou T, Seth A, Hertzog PJ and Kola I: ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum Mol Genet 12: 247-255, 2003. (Pubitemid 36204422)
90. Venanzoni MC, Robinson LR, Hodge DR, Kola I and Seth A: ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. Oncogene 12: 1199-1204, 1996. (Pubitemid 26127250)
91. Kiesslich T, Krammer B and Plaetzer K: Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 13: 2189-2204, 2006. (Pubitemid 44132609)
92. Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J and Agostinis P: Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J 20: 756-758, 2006. (Pubitemid 46671205)
93. Ruhdorfer S, Sanovic R, Sander V, Krammer B and Verwanger T: Gene expression profiling of the human carcinoma cell line A-431 after 5-aminolevulinic acid-based photodynamic treatment. Int J Oncol 30: 1253-1262, 2007.
94. Yamada KM and Even-Ram S: Integrin regulation of growth factor receptors. Nat Cell Biol 4: E75-E76, 2002.
95. Huygens A, Kamuhabwa AR, Roskams T, van Cleynenbreugel B, van Poppel H and de Witte PA: Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells. J Urol 174: 69-72, 2005. (Pubitemid 40825674)
96. Galaz S, Espada J, Stockert JC, Pacheco M, Sanz-Rodriguez F, Arranz R, Rello S, Canete M, Villanueva A, Esteller M and Juarranz A: Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment. J Cell Physiol 205: 86-96, 2005. (Pubitemid 41262854)
97. Pallero MA, Elzie CA, Chen J, Mosher DF and Murphy- Ullrich JE: Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J 22: 3968-3979, 2008.
98. Riento K, Villalonga P, Garg R and Ridley A: Function and regulation of RhoE. Biochem Soc Trans 33: 649-651, 2005.
99. White JM: ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15: 598-606, 2003.
100. Yang P, Baker KA and Hagg T: The ADAMs family: coordinators of nervous system development, plasticity and repair. Prog Neurobiol 79: 73-94, 2006. (Pubitemid 44247280)
101. Grossmann J: Molecular mechanisms of 'detachment-induced apoptosis-Anoikis'. Apoptosis 7: 247-260, 2002.
102. Luna MC, Ferrario A, Rucker N and Gomer CJ: Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. Cancer Res 55: 1820-1823, 1995.
103. Densham RM, Todd DE, Balmanno K and Cook SJ: ERK1/2 and p38 cooperate to delay progression through G1 by promoting cyclin D1 protein turnover. Cell Signal 20: 1986-1994, 2008.
104. Wang J, Yin DP, Liu YX, Baer R and Yin Y: Dual specificity phosphatase 1/CL100 is a direct transcriptional target of E2F-1 in the apoptotic response to oxidative stress. Cancer Res 67: 6737-6744, 2007.
105. Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene 27: 6245-6251, 2008.
106. Luna M, Wong S, Ferrario A and Gomer CJ: Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway. Photochem Photobiol 84: 509-514, 2008.
107. Novosyadlyy R, Kurshan N, Lann D, Vijayakumar A, Yakar S and LeRoith D: Insulin-like growth factor-I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum. Cell Death Differ 15: 1304-1317, 2008. (Pubitemid 351984759)
108. Liang SH, Zhang W, McGrath BC, Zhang P and Cavener DR: PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochem J 393: 201-209, 2006. (Pubitemid 43049316)
109. Chen JC, Wu ML, Huang KC and Lin WW: HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression. Cardiovasc Res 80: 138-150, 2008.
110. Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N and Yamada N: TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 12: 107-113, 2006. (Pubitemid 43050084)
111. Mikstacka R, Przybylska D, Rimando AM and Baer- Dubowska W: Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol Nutr Food Res 51: 517-524, 2007. (Pubitemid 47083688)